Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder.

This study provides real-world evidence that lithium is associated with decreased risk for respiratory infections and suggests that the repurposing potential of lithium for potential antiviral or antibacterial effects is worthy of investigation.